Filing Details

Accession Number:
0000919574-25-003572
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-12 20:27:44
Reporting Period:
2025-06-10
Filing Date:
2025-06-12
Accepted Time:
2025-06-12 20:27:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
834365 Biolife Solutions Inc BLFS Electromedical & Electrotherapeutic Apparatus (3845) 943076866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534260 Casdin Partners Gp, Llc 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
1534261 Casdin Capital, Llc 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
1534264 Eli Casdin 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
1534265 Casdin Partners Master Fund, L.p. 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
Transaction Summary
Sold: 1,000,000 shares Avg. Price: $23.80 Total Value: $23,800,000.00
Number of Shares After Transactions: 7,707,165 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Disposition 2025-06-10 1,000,000 $23.80 7,707,165 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.